Enzyme replacement therapy in Fabry cardiomyopathy: an incomplete treatment

被引：0
|
作者：
Nicholls, Kathleen [1 ,2 ]
机构：
[1] Royal Melbourne Hosp, Nephrol, Parkville, Vic, Australia
[2] Univ Melbourne Med, Royal Melbourne Hosp, Parkville, Vic, Australia
来源：
HEART | 2024年 / 110卷 / 15期
关键词：
genetic diseases; inborn; metabolic diseases; cardiomyopathy; restrictive; CARDIAC INVOLVEMENT; AGALSIDASE-BETA; DISEASE;
D O I：
10.1136/heartjnl-2024-324238
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：971 / 971
页数：1
相关论文
共 50 条
  • [21] Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
    Pogoda, Christian
    Brand, Stefan-Martin
    Duning, Thomas
    Schmidt-Pogoda, Antje
    Sindermann, Juergen
    Lenders, Malte
    Brand, Eva
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [22] Effects of enzyme replacement therapy in Fabry neuropathy
    Politei, J. M.
    Dubrovsky, A.
    Verdugo, R.
    CLINICAL THERAPEUTICS, 2007, 29 : S30 - S31
  • [23] Enzyme replacement therapy in an adolescent with Fabry disease
    Sabine Illsinger
    Thomas Luecke
    Hendrik Langen
    Anibh M. Das
    European Journal of Pediatrics, 2003, 162 : 522 - 523
  • [24] Utility of enzyme replacement therapy in Fabry disease
    Manuel Politei, Juan
    Dubroysky, Alberto
    MEDICINA CLINICA, 2010, 134 (09): : 402 - 405
  • [25] Fabry disease: Efficacy of enzyme replacement therapy
    Zampetti, A.
    Amerio, P. L.
    De Simone, C.
    Antuzzi, D.
    Ricci, R.
    Feliciani, C.
    ACTA PAEDIATRICA, 2007, 96 : 102 - 102
  • [26] Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy
    Lui, Charles Y.
    Ju, Hyunsu
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (11): : 1557 - 1558
  • [27] Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy
    Beer, Meinrad
    Weidemann, Frank
    Breunig, Frank
    Knoll, Anita
    Koeppe, Sabrina
    Machann, Wolfram
    Hahn, Dietbert
    Wanner, Christoph
    Strotmann, Jorg
    Sandstede, Jorn
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10): : 1515 - 1518
  • [28] Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathy
    Chen, Kuan-Hsuan
    Chou, Yueh-Ching
    Hsiao, Chen-Yuan
    Chien, Yueh
    Wang, Kang-Ling
    Lai, Ying-Hsiu
    Chang, Yuh-Lih
    Niu, Dau-Ming
    Yu, Wen-Chung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 486 : 293 - 299
  • [29] Evaluating Enzyme Replacement Therapy in Fabry Disease
    Koskenvuo, Juha W.
    Kantola, Ilkka M.
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (06) : 573 - 574
  • [30] TRIGGER FOR INITIATING ENZYME REPLACEMENT THERAPY (ERT) TREATMENT IN CHILDREN WITH FABRY DISEASE
    Ramaswami, U.
    Hendricksz, C.
    Wijburg, F.
    Bouwman, M.
    Linhart, A.
    Pintos Morell, G.
    Kalkum, G.
    Parini, R.
    Beck, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S150 - S150
12345